Lupin receives US FDA Establishment Inspection Report for Somerset facility

Lupin has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility in Somerset, New Jersey. The report follows an inspection conducted from 27 January to 31 January 2025.

Nilesh Gupta, Managing Director of Lupin, stated, “We are very pleased to have received the EIR for our Somerset facility. This milestone underscores our commitment to upholding the highest standards of quality and compliance, solidifying our position as a leading pharmaceutical manufacturer.”

Related Posts

Cough Syrup Took Betul Boy’s Voice

Nagpur:  For nearly two months, a mother from Betul fought a lonely battle as her 3.5-year-old son Harsh battled renal failure and swelling in the brain at AIIMS Nagpur, caused…

Comply with global practices by Jan 1 or shut shop: CDSCO to pharma manufacturers after cough syrup deaths

The CDSCO has made clear there will be no further opportunities for extensions, meaning any units that remain non-compliant by the deadline must suspend operations until requirements are met. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cough Syrup Took Betul Boy’s Voice

Cough Syrup Took Betul Boy’s Voice

Comply with global practices by Jan 1 or shut shop: CDSCO to pharma manufacturers after cough syrup deaths

Comply with global practices by Jan 1 or shut shop: CDSCO to pharma manufacturers after cough syrup deaths

Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India

Novo Nordisk Partners With Emcure To Launch Weight Loss Drug Poviztra In India

Seven state-of the-art common infra facilities to come up at Ujjain Medical Devices Park

Seven state-of the-art common infra facilities to come up at Ujjain Medical Devices Park

Kala Amb firm linked to drug racket sealed by NCB

Kala Amb firm linked to drug racket sealed by NCB

Expired medicines: 2 hospitals barred from PM-JAY

Expired medicines: 2 hospitals barred from PM-JAY